The company’s investment strategy is aimed at the investigation, production development and import substitution of medicines and vaccines used in socially significant areas of medicine, such as oncological, autoimmune, infectious and orphan diseases.
the structure of Petrovax
- R&D center
- BD department
- Clinical studies and product registration
- Administration Office
- API & Finished-dose
- Manufacturing Site
- Quality Control
- Marketing and Sales Force
- Pharmacovigilance
The company was founded in 1996 by a team of Russian scientists.
mission
Innovative products for health and better quality of life
values